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This study investigated the impact of demographic, so-
cial, and clinical factors on cancer patients’ self-ratings
of health-related quality of life (HRQL). The sample
consisted of 1342 ethnically diverse individuals in treat-
ment at four member institutions of the Eastern Coop-
erative Oncology Group (ECOG). Multivariable regres-
sion analyses were employed to determine the relationship
between demographic variables (age, gender, race/eth-
nicity, socio-economic status (SES), living arrangement),
clinical factors (performance status rating (PSR), disease
type, disease stage), and social characteristics (spiritual
beliefs, religious affiliation, relationship with physician)
and five outcome measures of HRQL. The dependent
variables, four dimensions of HRQL and overall HRQL,
were measured by the Functional Assessment of Cancer
Therapy-General (FACT-G) Quality of Life Measure-
ment System. The results indicated that the full set of
predictor variables accounted for 45% of the variance
in patients’ reporting of overall HRQL, 25% of the
variance in physical well-being, 27% of the variance in
social well-being, 30% of the variance in emotional
well-being, and 41% of the variance in the area of func-
tional well-being. The findings suggest that there are
multiple factors that influence an individual’s assess-
ment of their HRQL and that these factors need to be
considered in the management and treatment of cultur-
ally diverse cancer patients.
 
Introduction
 
Health-related quality of life (HRQL) is multidi-
mensional and can be defined as a subjective as-
sessment of physical, functional, emotional, and
social-well being relative to one’s current and fu-
ture expectations [1–3]. Minority patients such as
Hispanics and African Americans are often ex-
cluded from HRQL evaluations due to differences
in language and literacy levels. Although numer-
ous studies have examined the psychometric prop-
erties of HRQL assessment instruments in clinical
trials in great detail, there is limited knowledge
pertaining to demographic, social, and clinical fac-
tors affecting the variability in HRQL reports
among minority cancer patients. Thus, the pur-
pose of this paper is to examine the extent to
which demographic, social, and clinical character-
istics influence the reporting of HRQL by cancer
patients.
 
Conceptual Framework
 
Wilson and Cleary [4] indicate the need for fur-
ther examination into the determinants of HRQL.
Two different models for assessing the impact of
clinical, social, and demographic factors on HRQL
reports have been offered.
 
Clinical Paradigm: Biomedical Model
 
The clinical paradigm or biomedical model centers
on etiologic agents, pathological processes, and bi-
ological and physiological outcomes. [4] The pur-
pose of this model is to distinguish at-risk groups
in need of treatment or diagnostic intervention.
Wilson and Kaplan [5] report three limitations of
the biomedical model: 1) the definition of health
in this model focuses on cells and organs rather
than on individual functioning; 2) there is a vague
relationship between physiological and biological
processes and an individual’s symptoms; and 3)
this model does not meet the needs and expecta-
tions of the patients. Numerous studies have ex-
amined the association between performance sta-
tus (a rating of activity level) and HRQL [1,3,6–9].
Other clinical factors which have been commonly
 
Address correspondence to: 
 
George J. Wan, PhD, MPH,
Merck & Co., Inc., P.O. Box 4, WP39-170, West Point,
PA 19486. E-mail george_wan@merck.com
 Demographic, Clinical, & Social Factors on HRQL
 
309
 
contended to influence HRQL reports in cancer
patients include current clinical status, choice of
treatment, disease type, and disease stage [10].
Several studies have assessed the relationship be-
tween disease type, disease stage, and HRQL
[3,9,11–14].
 
Social Science Paradigm: Social Contextual Model
 
The social science paradigm or social contextual
model focuses on determinants of HRQL that are
associated with cultural, economic, political, and
physical and social/personal environments of the
population or individual [15,16]. Cultural charac-
teristics include values, beliefs, and rituals and
their meanings in a particular population. Eco-
nomic indicators include income level, housing,
employment, and environmental conditions. Phys-
ical factors include the presence of carcinogens, air
pollution, and hazardous waste. Social and demo-
graphic attributes include age, gender, race/ethnic-
ity, social position, social support, living arrange-
ment, diet, and exercise. Prior studies have reported
that HRQL in cancer patients tended to be higher
among those with higher socio-economic status
(SES) [17–20], men [21–24], older adults [3,6,7],
those who live with others [3] and those with
stronger spiritual beliefs [9].
 
Integrative Paradigm: Clinical and Social Model
 
Although Wilson and Cleary [4] have recently
proposed an integrative HRQL model that at-
tempted to link clinical variables with HRQL con-
cepts, an integrative paradigm is needed to link
both the clinical and social contextual models.
The explanatory factors of an integrative HRQL
model could include demographic (age, gender,
race/ethnicity, socio-economic status, living ar-
rangement), clinical (performance status, disease
type, disease stage) and social (spiritual beliefs, re-
ligious affiliation, relationship with physician) fac-
tors. In this study, a conceptual model was devel-
oped in order to assess the impact of demographic,
clinical, and social variables on HRQL reports in
cancer patients.
 
Applicability of HRQL in Multiple Racial/
Ethnic Groups
 
Variations in HRQL may be explained by race
and/or ethnicity. Numerous methodological prob-
lems have been encountered when developing
HRQL instruments for minority groups. These is-
sues include the need for idiomatic translations,
lack of familiarity with the survey questions and
low acculturation and literacy levels [25,26]. Al-
though health differentials between whites and
nonwhites continue to exist, the actual magnitude
of the disparity is difficult to interpret because of
conceptual and methodological issues. For in-
stance, methodological errors may be due to dif-
ferential sample selection, biases in hospital-based
data due to ethnic/racial differences in health ser-
vices utilization, or biases in clinical diagnosis
among minority populations [27]. Cultural bias
may be present when measuring HRQL across dif-
ferent ethnic groups. Cultural bias in HRQL mea-
surement includes differences in 1) the conceptual-
ization of HRQL across societal and cultural
contexts; 2) the levels of observation that are re-
lied on to indicate HRQL dimensions; and 3) the
significance of the various HRQL scales measured
[28]. There is also a lack of consistency in cross-
cultural evaluation of instrument equivalence.
Various dimensions of equivalence have been pro-
posed: content, semantic, technical, criterion, and
conceptual [29]. Guillemin et al. [30] recommend
obtaining semantic, idiomatic, experimental, and
conceptual equivalence in translation by using
back-translation methods and expert review, in
addition to pretesting and reevaluating the weight
of the dimension scores for both specific and ge-
neric HRQL measures. In multinational clinical
trials, language-adopted versions focus mainly on
translation issues and less on psychometric equiv-
alence across language versions [31]. Cella et al.
[32] propose four factors that need to be ad-
dressed simultaneously when planning, imple-
menting, and analyzing HRQL across cultures in
clinical oncology trials: 1) natural history of the
disease or condition, 2) characteristics of the pop-
ulation, 3) treatment type, and 4) structure and
function of the clinical trial organization. The nat-
ural history of the disease is dependent on the con-
ditions relating to the presence of symptoms, life
threat, functional impact, and acute versus chronic
presentation of the symptoms. Population charac-
teristics include demographic variables and comor-
bid conditions. Adverse effects may vary along dif-
ferent treatment modalities. The structure of the
clinical trial organization may be indicative of the
centralization of personnel and resources within
the organization. Hispanic HRQL responses are
likely influenced by Hispanic values such as “sim-
patia” (a necessity for harmonious social relations),
familialism, and power distance (preference for
social power) [33]. African American HRQL re-
sponses are likely influenced by African American
values such as strong church participation, famil-
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ialism, community unity, and self-determination
[34,35]. More research is clearly needed regarding
the determinants of HRQL in minority popula-
tions.
 
Methods
 
Research Questions
 
This study is guided by three primary research
questions: 1) What are the effects of demographic
factors (age, gender, race/ethnicity, socio-economic
status, living arrangement) on HRQL? 2) What
are the effects of clinical variables (performance
status, disease type, disease stage) on HRQL? and
3) What are the effects of social characteristics
(spiritual beliefs, religious affiliation, relationship
with physician) on HRQL?
 
Hypotheses
 
Previous studies have indicated that five variables
are significantly related to HRQL: performance
status, SES, gender, age, and living arrangement.
These studies found that HRQL tended to be
lower among those with poorer performance sta-
tus [1,3,6–9], those of lower SES [17–20], women
[21–24,36,37], younger adults [3,6,7,35], and those
who live alone [3]. Thus, it was hypothesized that
individuals with poorer performance status, those
with lower SES, women, younger adults, and those
who live alone would report lower overall HRQL.
Relationships between disease type, disease stage,
survey method, race/ethnicity, religious affiliation,
patient-physician, spiritual beliefs, and HRQL are
largely unknown. Consequently, no specific hy-
potheses were offered concerning their association
with HRQL.
 
Sample
 
A convenience sample (N 
 

 
 1342) of patients
from four Eastern Cooperative Oncology Group
(ECOG) institutions was enrolled in a multicenter
oncological study during May 1994 to September
1996. Research sites included: Grady Memorial
Hospital Minority Community Clinical Oncology
Program (CCOP)/Emory University Hospital, At-
lanta, GA (N 
 

 
 333); San Juan Minority CCOP,
Puerto Rico (N 
 

 
 473); and Rush-Presbyterian-St.
Luke’s Medical Center/Cook County Hospital,
Chicago, IL (N 
 

 
 484). Fifty-two patients were
enrolled from other institutions. Patients selected for
this study met the following inclusion criteria: over
18 years of age and diagnosed with either breast
cancer, colon cancer, head/neck cancer, or lung can-
cer. Participants had completed a minimum of two
cycles of chemotherapy treatment (1 month for con-
tinuous chemotherapy patients) or 10 radiation ther-
apy treatments. The latter criterion was required
in order to include individuals who were more
likely to be experienced informants with regard to
treatment side effects.
 
Operationalization of Study Variables
 
Independent Variables.
 
Independent variables
were classified into three distinct groups: demo-
graphic, clinical, and social characteristics. These
variables are at least ordinal in nature and are ap-
proaching the interval level of measurement. De-
mographic variables included age, gender, living
arrangement, race/ethnicity, and socio-economic
status. Gender (0 
 

 
 Men; 1 
 

 
 Women) and living
arrangement (0 
 

 
 Lives alone; 1 
 

 
 Lives with
other(s)) were coded as dichotomous variables.
Dummy variables were created for race/ethnicity
(Hispanic, Black nonHispanic, and White nonHis-
panic as the reference group). The Hollingshead
Index of Social Position [38,39] is a five-level ordi-
nal scale that classifies respondents as: 1) lower
class (8–19), 2) working class (20–29), 3) lower-
middle class (30–39), 4) middle class (40–54), and
5) upper class (55–66). It was derived from the
sum of the occupational factor weighted by five
and the educational factor weighted by three. The
occupational and educational weights are further
described elsewhere [38,39]. Three-factor and
four-factor indexes have been developed, but the
two-factor index is the most commonly used and
validated [38,40]. For cancer patients who were
married or cohabitating more than 1 year, a four-
factor index was calculated (averaging the SES of
both partners). For single cancer patients living
alone or cohabitating less than 1 year, a two-fac-
tor index was calculated.
Clinical variables included performance status,
disease type and disease stage. Zubrod et al. [41]
developed the ECOG Performance Status Rating
(PSR). This is a single item rating of activity level.
Although performance status can be evaluated by
both the provider (nurse or physician) and the pa-
tient, the physician’s appraisal was used as the ba-
sis for comparison on the measured variables in
this study. The range is from 0 to 4, where 0 
 

 
fully ambulatory without symptoms; 1 
 

 
 fully
ambulatory with symptoms; 2 
 

 
 requiring bed
rest (or equivalent) less than half of the waking
day; 3 
 

 
 requiring bedrest (or equivalent) greater
than half of the waking day; and 4 
 

 
 bedridden.
Three patients in this study who were rated “4”
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on the PSR were included with patients rated “3”
due to their small number (PSR was thus recoded
0 through 3). Binary variables were created for the
following disease types: breast, colon, lung, and
head/neck (as the reference group). Cancer disease
staging was done by the patient’s oncologist and
then subsequently confirmed by a nurse examiner
(the diagnosis and extent of disease were ab-
stracted from the medical record by the inter-
viewer and then subsequently confirmed by the
oncologist for the sites in Puerto Rico). Disease
staging is based on the National Cancer Institute
(NCI) codes: Stage I—in situ (noninvasive malig-
nancy), Stage II—local (invasive cancer confined
to the site of origin), Stage III—regional (spread
by direct extension to adjacent organs or to re-
gional lymph nodes), and Stage IV—distant me-
tastases (spread to distant organs or lymph nodes)
[42].
Social factors included spiritual beliefs, reli-
gious affiliation, and relationship with physician.
Dummy variables were created for religion (Cath-
olic, Protestant, No Affiliation, and Other Reli-
gion as the reference group). Eighteen patients in
this study who were classified as Jewish were in-
cluded with patients in the reference group. Spiri-
tual beliefs were estimated using a face- and con-
tent-valid set of 12 questions contained within the
Functional Assessment of Cancer Therapy (FACT)
Quality of Life Measurement System. A detailed
psychometric analysis of this FACT subscale is in
preparation [43]. For the purpose of this analysis,
an index was calculated by summing the 12 Lik-
ert-type items to form a single score of a patient’s
spiritual beliefs (after two negatively worded items
were reverse scored). The 12 items assessed an in-
dividual’s sense of meaning and purpose in life
(e.g., “I feel a sense of purpose in my life”), an in-
dividual’s relationship with his or her faith (e.g.,
“I find strength in my faith”) and hope/self-effi-
cacy (e.g., “I know that whatever happens with
my illness, things will be okay”). Higher scores re-
flect stronger spiritual beliefs. Internal consistency
using Cronbach’s alpha was 0.85 among the valid
cases in this sample (N 
 

 
 1276). Since there is no
“gold standard” for measuring spiritual beliefs,
validity testing for this scale was limited to assess-
ment of content validity. To establish content va-
lidity, items were drawn from a literature review
and the authors’ experience. The relationship with
physician subscale consists of two items from the
Functional Assessment of Cancer Therapy-Gen-
eral (FACT-G) scale, which rate a physician’s in-
terpersonal and technical skills. Internal consis-
tency using Cronbach’s alpha was 0.79 among
valid cases in this sample (N 
 

 
 1320).
 
Dependent Variables.
 
The dependent variables,
four subscales of HRQL (physical, social, emo-
tional, and functional well-being) and overall
HRQL (the sum of the four subscales), were mea-
sured by the FACT-G (Version 3) Quality of Life
Measurement System [44]. The FACT-G Quality
of Life Measurement System was validated and
developed by Cella and colleagues [1,2,44] at
Rush-Presbyterian-St. Luke’s Medical Center, Chi-
cago, IL. The FACT-G has been demonstrated to be
a valid and reliable instrument for assessing HRQL
in cancer and HIV patients [1,2,44–47]. The scale
was created using information obtained from 135
patients with advanced cancer and 15 specialists
in oncology, and then subsequently validated on a
separate sample of 630 patients with varying de-
grees of cancer severity and type [1,44]. Patients
appraise all items using a five-point Likert rating
scale ranging from “not at all” to “very much.” Test-
retest reliability coefficients of each of the sub-
scales range from 0.82 to 0.92 [44]. Concurrent
validity is established by strong Pearson correla-
tions with the Functional Living Index-Cancer
(0.79) and a patient-rated version of the Quality
of Life Index (0.74) [44]. Construct validity is sup-
ported by: 1) moderate to high correlations with
mood state (0.57–0.69), 2) moderate correlation
with activity level (
 

 
0.56; negative direction due
to reverse scoring) and a low correlation with so-
cial desirability (0.22) [44]. Data from factor anal-
ysis of 545 patients with a variety of cancer diag-
noses indicated a six-factor solution using an
oblique rotation which accounted for 51% of the
total variation [44]. The FACT has also been vali-
dated in Spanish-speaking cancer patients, includ-
ing those with low literacy levels [45,46]. Further-
more, semantic, content, and technical equivalence
were demonstrated with multiple bilingual advi-
sors and confirmed with a second back-transla-
tion. Details of the FACT translation methodol-
ogy and pretesting results are available elsewhere
[45,46]. The FACT uses a 28 to 40 item compila-
tion of a generic measure (28 items) and six specific
subscales, which refer to symptoms or problems re-
lated to various diseases. This is a comprehensive
HRQL instrument that assesses five dimensions of
HRQL: 1) physical well-being, 2) social/family well-
being, 3) relationship with doctor, 4) emotional
well-being, and 5) functional well-being. An over-
all index of HRQL can be calculated by summing
the subscales of HRQL. “Physical well-being” con-
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sists of seven items (range: 0–28) that describe the
presence of physical distress or symptoms such as
pain, nausea or fatigue. “Social/family well-being”
consists of seven items (range: 0–28) including fam-
ily/friend relationships and sexuality. “Relationship
with physician” consists of two items (range: 0–8)
that rate a physician’s interpersonal skills and
technical competence. “Emotional well-being” con-
sists of five items (range: 0–20) that relate to the
presence of psychological distress or symptoms
such as anxiety or depression. “Functional well-
being” consists of seven items (range: 0–28) that
refer to an individual’s mobility or current level of
functioning (e.g., working and sleeping habits).
Based on the review of the literature and the prob-
lematic ceiling effects, it was decided to exclude
the “relationship with physician” subscale as one
of the dependent variables in this analysis. In addi-
tion, the current version of the FACT-G excludes
the relationship with physician subscale from the
scoring algorithm [47]. For each of the four sub-
scales of HRQL and overall HRQL score, items
were summed after reverse scoring the negatively
worded items so that a higher score on a scale re-
flected a favorable response.
 
Analytical Strategy
 
Pearson product-moment correlation coefficients
(
 
r
 
) and variance inflation factors (VIF) were used
to analyze the existence of potential collinearity
problems (VIF 
 

 
 10) among the independent vari-
ables. Ordinary-least squares (OLS) multiple re-
gression analyses using the forced-entry method
were performed. To allow a testing of the hypoth-
eses of interest, a hierarchical method of inclusion
was employed, with list-wise exclusion of missing
data. List-wise deletion is more appropriate for
this data since it eliminates a case if it has a miss-
ing value for any of the variables on the list. Inde-
pendent variables were entered via three blocks.
Demographic variables were entered first followed
by clinical and then social variables. The order of
entry was thus as follows: 1) Model 1—demo-
graphic variables (age, gender, race/ethnicity, SES,
living arrangement), 2) Model 2—clinical vari-
ables (PSR, disease type, disease stage) and 3)
Model 3—social variables (spiritual beliefs, reli-
gious affiliation, relationship with physician). Ad-
ditional analyses (not shown) using first-order in-
teraction terms for race/ethnicity, SES, and spiritual
beliefs, however, did not identify meaningful bi-
ases in the linear regression models. For simplicity
and clarity, only the standardized regression coef-
ficients that are statistically significant at the 0.05
level or beyond are reported. Unstandardized re-
gression coefficients do not suggest any different
conclusions and are available upon request from
the first author. The Statistical Package for the So-
cial Sciences (SPSS 9.0) for Windows [48] was uti-
lized for all statistical analyses.
 
Results
 
Table 1 shows the baseline means, standard devia-
tions, percentages scoring at the scale floors and
ceilings, and the internal consistency reliability co-
efficients for the five FACT-G subscales and the
overall HRQL index used in the regression analy-
ses. Problematic ceiling effect levels (
 

 
15%) were
observed for the relationship with doctor subscale.
Internal consistency coefficients, measured by Cron-
bach’s alpha, were generally consistent with the
original validation sample (not shown) [2]. How-
ever, the reliability coefficient for this sample ap-
peared to be lower for the emotional well-being
subscale compared to the original validation sam-
ple (0.66 versus 0.74; 
 
P
 
 
 

 
 0.05). These observed
disparities may be due to study sample differences
such as race/ethnicity, disease stage, and disease
type. Table 2 displays the characteristics of the
sample. The average age of the study participant
was 58 years old. Eighty-three percent of the pa-
tients had normal functioning or the presence of
minor symptoms (ECOG PSR 
 

 
 0 or 1) and close
to 60% of the participants were in the lower class
SES category. The sample was predominately
women (61%), Hispanic (41%), Catholic (41%),
and living with other(s) (83%).
 
Multivariable Regression Analyses of
Dimensions of HRQL
 
Multivariable regression models were evaluated in
order to further explore significant predictors of
the dimensions of HRQL. Variance inflation fac-
tors (VIF) indicated the absence of serious col-
linearity problems (the VIF computed for the inde-
 
Table 1
 
FACT-G means, standard deviations, percent 
scoring at the scale floor (floor), percent scoring at the scale 
ceiling (ceiling) and coefficient alphas
 
FACT-G (k items) Mean SD Floor Ceiling
Physical well-being (7) 21.0 5.9 0.1 10.9
Social well-being (7) 21.8 5.2 0.1 14.1
Relationship w/ doctor (2) 6.9 1.6 0.7 55.4
Emotional well-being (5) 18.7 4.5 0.1 14.6
Functional well-being (7) 18.2 6.8 0.2 7.9
Overall HRQL (26
 
*
 
) 79.7 16.7 0.1 0.5
 
*
 
Excludes two items from the “Relationship with Doctor” subscale.
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pendent variables were all less than 10). Independent
variables in aggregate accounted for 25% of the
variance in patients’ reports of physical well-being,
27% of the variance in social well-being, 30% of
the variance in emotional well-being, and 41% of
the variance in the area of functional well-being.
All four of the regression models were statistically
significant at the 
 
P
 
 
 

 
 .001 level.
Clinical factors such as performance status rating,
lung cancer diagnosis, and disease stage were sig-
nificant predictors of certain dimensions of HRQL.
For instance, respondents with better performance
status reported higher levels of physical well-being,
emotional well-being, and functional well-being.
In contrast, lung cancer patients indicated lower
levels of functional well-being. More advanced can-
cer patients indicated lower physical, emotional,
and functional well-being scores.
Differences in HRQL subscale scores existed
among gender, age, living arrangement, race/ethnic-
ity, spiritual belief, and religious groups. Individuals
with higher spiritual belief scores had higher scores
in all five areas of HRQL. Religious affiliation as
well as nonaffiliation were significant predictors
of specific areas of HRQL (see Table 3). Hispanics
indicated lower levels of social and functional
well-being compared to whites. Black nonHispan-
ics reported lower social, emotional, and func-
tional well-being scores compared to whites. Fe-
males reported higher functional well-being than
men. Older patients had higher scores in the areas
of physical, emotional, and functional well-being.
Individuals who live with other(s) reported higher
social and functional well-being. Individuals who
reported a favorable relationship with their physi-
cian had higher social and functional well-being
scores compared to those individuals who re-
ported a poor relationship with their physician.
 
Table 2
 
Sample attributes
 
*
 
Variable Number Percent (%) or Range
Performance status rating
0 
 

 
 normal activity 640 48.4%
1 
 

 
 some symptoms, but I can walk and I don’t spend extra time in bed 455 34.4%
2 
 

 
 need some time in bed, but it is less than 50% of normal daytime 171 12.9%
3 
 

 
 need to be in bed greater than 50% of normal day
 
†
 
55 4.2%
Disease type
Breast cancer 533 39.7%
Colon cancer 258 19.2%
Head/neck cancer 235 17.5%
Lung cancer 316 23.5%
Disease stage
1 
 

 
 in situ 366 27.4%
2 
 

 
 local 316 23.7%
3 
 

 
 regional 364 27.2%
4 
 

 
 distant metastases 290 21.7%
Hollingshead Two-Factor Index (SES) M 
 

 
 1.7; SD 
 

 
 1.0 1–5
I 
 

 
 lower class (8 to 19) 744 57.6%
II 
 

 
 working class (20 to 29) 263 20.4%
III 
 

 
 lower-middle class (30 to 39) 176 13.6%
IV 
 

 
 middle class (40 to 54) 96 7.4%
V 
 

 
 upper class (55 to 66) 12 0.9%
Gender
0 
 
 
 
men 525 39.1%
1 
 

 
 women 817 60.9%
Age (in years) M 
 

 
 57.9; SD 
 

 
 12.2 18–90
Lives with other(s)
0 
 

 
 no 232 17.3%
1 
 

 
 yes 1110 82.7%
Race/ethnicity
Hispanic 556 41.4%
Black nonHispanic 433 32.3%
White nonHispanic (reference group) 353 26.3%
Religious affiliation
Catholic 544 40.5%
Protestant 398 29.7%
Jewish 18 1.3%
Other (reference group) 309 23.0%
No affiliation 73 5.4%
 
*
 
Some categories do not add up to 1342, because of missing data; some values do not add up to 100% due to rounding.
 
†
 
Three patients who rated themselves as a “4” on the PSR (“unable to get out of bed”) were included with patients rated “3.”
M, mean; SD, standard deviation.
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Regression Analysis of Overall HRQL
 
Regression analysis was used to determine the
most significant factors influencing the reporting
of overall HRQL in cancer patients Table 3. The
predictor variables accounted for 45% of the vari-
ability in overall HRQL. The model was statisti-
cally significant at the 
 
P
 
 
 

 
 .001 level. Individuals
with a favorable relationship with their physician,
normal functioning levels and stronger spiritual
beliefs reported higher HRQL. Religious affilia-
tion (as well as no religious affiliation) was also
associated with higher overall HRQL. However,
Hispanics, more advanced cancer patients, younger
adults, and those individuals who live alone indi-
cated lower HRQL scores than their counterparts.
 
Discussion and Conclusion
 
The purpose of this study was to explore the im-
pact of demographic, clinical, and social variables
on the reporting of HRQL in cancer patients.
HRQL instruments are frequently used in clinical
cancer trials. HRQL is subjective and therefore it
must be evaluated from the patient’s perspective.
Due to limitations in HRQL assessment methods
and costly administration time, patients with cul-
turally, linguistically, and educationally diverse
backgrounds are often excluded from the HRQL
component of clinical oncology research. As a re-
sult, there is a clear need to assess HRQL in mi-
nority populations.
Multivariable regression analyses were per-
formed. The results appear to be consistent with
findings of previous studies that identified lower
HRQL scores among those with poorer perfor-
mance status [1,3,6–8], lower physical well-being,
emotional well-being, functional well-being, over-
all HRQL in younger adult patients [3], and lower
SES [17–20]. This study also found that women
reported higher functional well-being scores than
men after adjusting for diagnosis. In contrast, pre-
vious studies indicated lower HRQL ratings
among women [21–24,36,37]. Previous research
indicates lower HRQL in women compared to
men is largely in the area of emotional well-being
[3,37]. However, multivariable analyses in this
study indicated that there were no significant dif-
ferences in the reporting of emotional well-being
among men and women. The functional well-
being subscale of the FACT contains all positively
worded items, rather than negative experiences
such as symptom-reporting. Thus, whereas women
do tend to report more symptoms than men, they
 
Table 3
 
Standardized regression coefficients obtained from the multivariable regression analyses of HRQL subscales
 
PWB SWB EWB FWB Overall HRQL
Variable M1 M2 M3 M1 M2 M3 M1 M2 M3 M1 M2 M3 M1 M2 M3
Demographic
Age .09
 
†
 
.11
 
†
 
.10
 
‡
 
.15
 
‡
 
.15
 
‡
 
.14
 
‡
 
.07
 
*
 
.06
 
*
 
.09
 
†
 
.10
 
‡
 
.09
 
‡
 
Female gender .14
 
‡
 
.09
 
†
 
.19
 
‡
 
.08
 
*
 
.07
 
*
 
.16
 
‡
 
Hispanic
 

 
.11
 
†
 
.08
 
*
 

 
.11
 
†
 

 
.18
 
‡
 

 
.13
 
‡
 
Black NH
 

 
.09
 
*
 

 
.09
 
*
 
.10† .13‡ .15‡ .08* .07* .08*
SES .07* .07* .08* .07* .08† .06* .05*
Lives with others .21‡ .21‡ .19‡ .10‡ .09‡ .07† .11‡ .10‡ .08†
Clinical
PSR .34‡ .31‡ .16‡ .09† .30‡ .23‡ .30‡ .23‡
Breast cancer
Colon cancer
Lung cancer .09†
Disease stage .14‡ .13‡ .09† .10‡ .06* .06* .11‡ .10‡
Social
Spiritual beliefs .22‡ .35‡ .48‡ .46‡ .50‡
Catholic .12‡ .11† .11‡ .14‡
Protestant .07*
Jewish
No affiliation .07* .09† .08† .09‡
RWD .19‡ .07* .09‡
R-square .03 .20 .25 .07 .07 .27 .03 .07 .30 .07 .18 .41 .05 .18 .45
Adjusted R-square .03 .19 .24 .06 .07 .26 .03 .06 .29 .06 .17 .40 .05 .17 .44
Model F 6.45‡ 27.0‡ 24.9‡ 14.3‡ 8.63‡ 27.3‡ 6.73‡ 8.52‡ 31.6‡ 14.0‡ 24.1‡ 50.6‡ 11.4‡ 23.7‡ 60.9‡
*P  .05; †P  .01; ‡P  .001.
Standardized regression coefficients not statistically significant at the 0.05 level or beyond are omitted for clarity.
PWB, Physical Well-Being; SWB, Social/Family Well-Being; RWD, Relationship with Doctor; EWB, Emotional Well-Being; FWB, Functional Well-Being.
M1  Model 1; M2  Model 2; M3  Model 3.
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may also tend to report more positive experiences
than men. In any event, after accounting for clinical
factors the difference detected is small and con-
fined to one FACT subscale in this sample. Over-
all, women and men appear to respond comparably.
Another significant finding is that there appear
to be differences in the reporting of functional
well-being among cancer diagnosis groups. Those
individuals who were diagnosed with lung cancer
reported lower functional well-being scores com-
pared to the other diagnosis groups. The differ-
ence makes clinical sense given the often symp-
tomatic condition of many lung cancer patients
compared to breast, colon, or even head and neck
cancer patients.
This study also found important ethnic, reli-
gious, and spiritual belief differences in the report-
ing of HRQL. There are two plausible explana-
tions for this apparent discrepancy. One may be a
bias (“differential item functioning”) of the HRQL
survey itself [27]. To address the possibility that
minority group differences might have arisen as a
result of differential item functioning, wherein cer-
tain items were systematically more likely to be fa-
vorably endorsed by one group over another, the
authors conducted a Rasch measurement analysis.
This analysis plots individual item difficulty by
race (e.g., black versus white), and thereby allows
for identification of items which are more likely to
be endorsed by one group over another. The bi-
variate plot of black versus white patients revealed
no evidence of differential item functioning (a de-
tailed presentation of this analysis is in prepara-
tion). Another plausible explanation is that ethnic
and racial group differences in HRQL reports may
be due to methodological error in the classifica-
tion of minority groups. For instance, there may
be significant within-group variations among His-
panics as well as black nonHispanics. Thus, the
heterogeneity of racial/ethnic groups defined in
this data set may be responsible for the variability
in HRQL reports. It appears that religious affilia-
tion and nonaffiliation are both related to HRQL.
Perhaps, it may be that the reference group (other
religion) was basically uncommitted to any partic-
ular belief system and that those with no affilia-
tion actually have a belief system, but it is not re-
lated to a formal institutionalized religion. Additional
analyses (not shown) indicate that those with evi-
dence of religious affiliation (Catholic, Protestant,
or other) were more likely to have stronger spiri-
tual beliefs than those with no affiliation. Further
research is needed to examine the impact of reli-
gious affiliation on HRQL reports.
Spiritual beliefs appear to be a meaningful and
salient factor for explaining the variation in HRQL
reports. This finding is consistent with previous
studies [9,43]. One possible explanation for this
strong relationship is that stronger spiritual beliefs
may directly affect psychological well-being and
thereby enhance overall HRQL. However, more
research is needed to delineate the relationship be-
tween spiritual beliefs and HRQL in persons af-
flicted with chronic diseases. On the other hand,
numerous gerontological studies have found a
positive correlation between religiosity and psy-
chological well-being [49–51]. Another possible
explanation is that perhaps stronger spiritual be-
lief lowers anxiety levels in individuals diagnosed
with cancer and in turn improves overall HRQL.
Kaczorowski [52] reported that persons with higher
levels of spiritual well-being have lower levels of
anxiety. Also, spiritual beliefs may reflect self-effi-
cacy or self-esteem. This could explain the strong
relationship between spiritual beliefs and HRQL.
Lewis [53] found that late-stage cancer patients
with greater personal control as measured by self-
esteem and anxiety were positively associated with
higher quality of life.
It is important to note that, conceptually,
HRQL and spiritual beliefs are distinct constructs.
However, methodological problems may arise when
measuring these concepts. For example, spiritual
beliefs and HRQL can be related within the con-
text of a person’s health condition. Also, it is quite
possible that apart from conceptual overlap of this
application, there is an inflation of association due
to method invariance (i.e., both scores are ob-
tained by self-report in the same setting). In that
light, the extent of the association between spiri-
tual beliefs and HRQL appears worthy of further
study. The authors also found that specific reli-
gious affiliation as well as religious nonaffiliation
were both associated with higher levels of overall
HRQL. Perhaps, individuals with strong spiritual
beliefs have higher overall HRQL irrespective of
their religious affiliation.
It is also important to note that gender, living
arrangement, and relationship with physician ap-
pear to have an influence on the reporting of over-
all HRQL. Females reported higher levels of func-
tional well-being than men. Those individuals
who live with other(s) indicated higher levels of
social well-being, functional well-being, and over-
all HRQL. Those who reported a better relation-
ship with their physician had higher social well-
being, functional well-being, and overall HRQL
scores. These differences detected in this study do
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not necessarily indicate disparities in need for re-
habilitative services but instead may be related to
reporting style [54]. For example, female patients
may report higher quality of life because of differ-
ences in their expectations compared with male
patients.
Further research is warranted to allow the in-
vestigators to better discriminate the relative influ-
ence of each of the independent variables as well
as their combined explanatory power. Additional
study is also needed to examine other factors
which may account for additional variation in
HRQL such as psychosocial factors that reflect a
patient’s personal expectations, attitudes, values,
preferences, and knowledge of HRQL. Wan et al.
[3] found that individuals who reported better-
than-expected treatment experience are more
likely to report a better relationship with their
doctors, physical well-being, social well-being,
emotional well-being, functional well-being, and
total HRQL. Becker has discussed the impact of
perceptions regarding physical threat of illness,
attitudes towards medicine, and perceptions
regarding the severity of symptoms on health
[55,56]. Lazaru’s cognitive appraisal model [57]
may be a useful tool for examining the role of cog-
nition in coping with cancer [58,59]. Perhaps can-
cer patients’ coping strategies also affect their
HRQL.
The implications of the findings reported in this
article must be considered within the context of
the study’s limitations. First, while the sample is
culturally diverse, the findings cannot be general-
ized to all individuals throughout the United
States or abroad. For example, there is a need to
examine reporting patterns of other North Ameri-
can minority groups such as Native Americans,
Asian Americans and French Canadians. Second,
the study design was cross-sectional, capturing in-
dividual reports of HRQL at a single point in
time. Thus, the findings must be interpreted as
correlational rather than reflecting cause-effect re-
lationships. In addition, there may be inter-corre-
lation among the independent variables which
may confound the interpretation of the results.
This assessment is also limited because of the ex-
ploratory nature of the analysis. There remains a
lack of consensus concerning which theoretical
approach is appropriate when analyzing the im-
pact of factors which influence HRQL reports.
Perhaps this and other studies will help move ex-
ploratory findings into confirmatory studies, thereby
clarifying the role of cross-cultural factors that in-
fluence the reporting of HRQL.
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